Latest Breaking News On - Pediatric advisory committee - Page 6 : comparemela.com
Alston & Bird Health Care Week In Review, September 3, 2021 - Food, Drugs, Healthcare, Life Sciences
mondaq.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mondaq.com Daily Mail and Mail on Sunday newspapers.
Alston & Bird Health Care Week in Review - September 2021 #1 | Alston & Bird
jdsupra.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jdsupra.com Daily Mail and Mail on Sunday newspapers.
The debate over vaccinating kids against Covid
politico.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from politico.com Daily Mail and Mail on Sunday newspapers.
(stock photo)
All public schools in Halifax Regional Municipality and surrounding areas not already doing so will close Tuesday and start preparations to move to at-home learning as of Thursday.
This move affects all pre-primary children and grades primary to 12 public school students in Halifax Regional Centre for Education (HRCE), as well as Conseil scolaire acadian provincial (CSAP) schools and Chignecto Central s schools in the Enfield, Elmsdale and Mount Uniacke areas.
Nova Scotia s Minister of Education and Early Childhood Development said the decision was made out of an abundance of caution and in consultation with public health. Moving schools in HRM and surrounding areas to at-home learning is a necessary step at this important juncture, said Derek Mombourquette in a news release. I know this will be difficult for some families, but Nova Scotians have shown time and time again that they ll step up in our fight against this virus.
BioMarin Completes Full Enrollment in Phase 2 Study of Vosoritide for Treatment of Infants and Young Children with Achondroplasia
Topline data expected to be available in mid-2022
News provided by
Share this article
Share this article
SAN RAFAEL, Calif., March 3, 2021 /PRNewswire/ BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced today that the company has completed full enrollment in a global Phase 2 randomized, placebo-controlled study of vosoritide, an investigational, once daily injection analog of C-type Natriuretic Peptide (CNP) for children with achondroplasia, the most common form of disproportionate short stature in humans. The 52-week study consists of approximately 70 infants and young children with achondroplasia, aged zero to less than five years old (60 months). The study will be followed by a subsequent open-label extension trial where all children receive active treatment. Children in this study will have completed a minimum three- or six-month baseline st